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Abstract
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in
elderly people worldwide. Cuticular drusen (CD) is a clinical subtype of AMD, which typi-
cally displays an earlier age at onset, and has a strong genetic component. Genetic stud-
ies support a role for rare sequence variants in CD susceptibility, and rare sequence
variants in the CFH gene have been identified in 8.8% of CD cases. To further explore the
role of rare variants in CD, we performed whole exome sequencing (WES) in 14 affected
members of six families and 12 sporadic cases with CD. We detected rare sequence vari-
ants in CFH and FBLN5, which previously were shown to harbor rare variants in patients
with CD. In addition, we detected heterozygous rare sequence variants in several genes
encoding components of the extracellular matrix (ECM), including FBLN1, FBLN3/
EFEMP1, FBLN5, FBLN6/HMCN1, FBN2, and COL15A1. Two rare pathogenic variants
were identified in the COL15A1 gene: one in a sporadic case and another was found to
segregate in a family with six affected individuals with CD. In addition, two rare pathogenic
variants were identified in the FGL1 gene in three unrelated CD cases. These findings
suggest that alterations in the ECM and in the coagulation pathway may play a role in the
pathogenesis of CD. The identified candidate genes require further analyses in larger
cohorts to confirm their role in the CD subtype of AMD. No evidence was found of rare
sequence variants in a single gene that segregate with CD in the six families, suggesting
that the disease is genetically heterogeneous.
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Introduction
Age-related macular degeneration (AMD, OMIM 603075) is a leading cause of visual
impairment and affects 8.7% of elderly people worldwide [1]. An early pathological symptom
is the formation of drusen in the macula, the central region of the retina that is necessary for
sharp and central vision. AMD is a clinically heterogeneous disorder that displays a broad spec-
trum of clinical appearances [2–5]. Cuticular drusen (CD, OMIM 126700) is a clinical subtype
of AMD, characterized by the presence of at least 50 small (25–75μm) uniformly sized hyper-
fluorescent drusen, scattered primarily in the macular region on fluorescein angiography (FA)
[6]. There is evidence that CD has a strong genetic component; CD often occurs in families
and it presents clinically at an earlier age at onset than AMD [7,8]. Also, the most commonly
associated environmental factor, smoking, shows a weaker association with CD than with the
non-CD type AMD [9]. Genetic studies further support that CD has a strong genetic compo-
nent by showing significant associations of CD with common variants (minor allele frequency
[MAF] 1%) in the CFH (OMIM 134370), ARMS2 (OMIM 611313) C2 (OMIM 613927)/CFB
(OMIM 138470), C3 (OMIM 120700), and APOE (OMIM 107741) genes [7,9]. Moreover, het-
erozygous mutations in CFH segregate in multiplex CD families [10,11] and a highly penetrant
AMD risk variant, p.Arg1210Cys in CFH, was identified in two CD cases [12]. Furthermore,
we recently demonstrated that 8.8% of CD cases harbor rare sequence variants (MAF 1%) in
CFH [12]. This evidence supports a strong genetic component in CD, but additional genetic
factors that contribute to CD susceptibility are yet to be discovered. Whole exome sequencing
(WES) selectively sequences all protein-coding regions of the genome, known as the exome.
Protein-coding regions are collectively approximately 30 megabases in size, spread across
180,000 exons that constitute 1% of the human genome [13], and are estimated to harbor 85%
of disease-causing mutations [14]. Therefore, WES offers an unprecedented opportunity to
study the role of rare sequence variants in protein-coding regions in complex diseases. In the
present study, we sought to determine the role of rare sequence variants in CD using WES. We
performed WES in 14 affected members of six families and 12 sporadic cases with CD. In addi-
tion, we conducted segregation analysis for rare sequence variants that were identified by WES,
in affected individuals of six families.
Materials and Methods
Patients
We performedWES in 14 affected members of six families and 12 sporadic cases with the CD
subtype of AMD (Figs 1 and 2). All study participants were selected from the European Genetic
Database (EUGENDA) and are of Caucasian descent. All participants underwent extensive ret-
inal examinations, which is described elsewhere in detail [12,15]. CD was diagnosed on the
basis of the clinical observation of a symmetrically distributed pattern in both eyes of at least
50 scattered, uniformly-sized, small (25–75μm), and hyperfluorescent drusen on FA in each
eye, and with a minimum of 20 drusen located outside the Wisconsin age-related maculopathy
grading template [16,17]. The EUGENDA study was approved by the local research ethics
committees (Commissie Mensgebonden Onderzoek Regio Arnhem-Nijmegen, the Nether-
lands, and Ethics Committee of the University Hospital Cologne, Germany). The study
adhered to the ARVO statement for the use of human subjects in ophthalmic and vision
research, and was performed in accordance with the tenets of the Declaration of Helsinki.
Written informed consent was obtained from all participants. Peripheral blood samples were
collected from all participants, and genomic DNA was isolated using the Chemagic STAR
DNA Blood4k kit (PerkinElmer, Waltham, MA, USA).
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Whole exome sequencing
The exomes of all study participants were captured using the SureSelect Human All Exon kit
version 2 (50Mb; Agilent Technologies, Santa Clara, CA, USA) using 3μg of genomic DNA.
Subsequently, captured libraries were sequenced on SOLiD4 or 5500xl sequencing platforms
(Life Technologies, Carlsbad, CA, USA). Reads were aligned to the reference human genome
(NCBI hg19) with SOLiD LifeScope version 2.1 or SOLiD BioScope version 1.3 software (Life
Technologies). Single nucleotide variants (SNVs) were called using the high-stringency
DiBayes algorithm, and small insertions and deletions were detected using the SOLiD small
Indel Tool (Life Technologies). The pathogenicity of missense variants were predicted in silico
using Polymorphism Phenotyping version 2 (PolyPhen-2) and Sorting Intolerant from Toler-
ant (SIFT) tools.
The exomes were analyzed for variants in 289 candidate genes for CD and atypical hemo-
lytic uremic syndrome (aHUS), because of their known allelic overlap [15,18,19]. The candi-
date genes were selected from known CD genes [5,7], known AMD loci [20], genes known to
be involved in monogenic macular degeneration (Retnet), and genes encoding components of
the complement system, coagulation system, innate immunity, endothelial cells, and the glo-
merular basement membrane (S1 Table) (Westra et al, in preparation). The exomes of the six
families were also analyzed for variants in all genes of the exome that were shared among all
affected individuals of all six families.
Fig 1. Pedigrees of six cuticular drusen (CD) families in which whole exome sequencing (WES) was performed.Circle and square symbols indicate
female and male individuals, respectively. Symbols with slashes indicate deceased individuals. Black and empty symbols indicate affected and unaffected
individuals, respectively. Asterisks indicate the family members for whom exome sequencing was performed. The numbers below the symbols indicate the
age at participation of family members.
doi:10.1371/journal.pone.0152047.g001
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Sanger sequencing
Sanger sequencing was performed to validate rare sequence variants identified by WES. In fam-
ilies, confirmed rare sequence variants were analyzed for segregation by Sanger sequencing in
available family members. Primers were designed with Primer3Plus software (Primer3Plus).
PCR was performed, and amplification products were sequenced using an automated
sequencer (BigDye Terminator, version 3, 3730 DNA analyzer; Applied Biosystems, Waltham,
MA, USA). Sequencing chromatograms were compared to the reference sequence using Conti-
gExpress (Vector NTI Advance, version 11.0, Life Technologies).
Results
Whole exome sequence analysis
WES was performed in 14 affected members of six families and 12 sporadic cases with the CD
subtype of AMD. We detected an average of 34,784 sequence variants per exome, with an aver-
age coverage of 70-fold. We subsequently focused our analyses on 289 candidate genes (S1
Table) and detected an average of 780 sequence variants in these genes per sporadic case (S2
Table). In the six families, identically annotated sequence variants (referred to as overlapping
variants) were selected that were found in all affected individuals of each family. An average of
508 overlapping variants were detected in these candidate genes per family (S2 Table). We next
applied rigorous filtering criteria to identify rare, functionally relevant sequence variants in the
Fig 2. Retinal images of 12 sporadic cuticular drusen (CD) cases for whom exome sequencing (WES) was performed. Panels A and B represent
colour fundus photographs (1A-12A) and fluorescein angiograms (FAs) (1B-12B) of 12 cases respectively. For cases 1–5 retinal images of the right eye are
shown, whereas for cases 6–12 retinal images of the left eye are shown. The CD phenotype presents with a large number of small and uniformly sized
hyperfluorescent drusen on FA.
doi:10.1371/journal.pone.0152047.g002
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candidate genes. The sequence variants were selected when they were present on 10 or more
(10) variant reads, and when they were present in 20 percent or more (20%) of the variant
reads. We then selected non-synonymous, coding insertion-deletions (indels), and splice
acceptor and donor site variants in the candidate genes, and detected an average of 133 variants
in each sporadic case, while on average 88 overlapping variants were detected in each family.
Finally, we selected rare sequence variants with a minor allele frequency of1% (MAF0.01)
in the 1000 Genomes project (1000 Genomes project) and the global MAF listing in the dbSNP
database (dbSNP database). These filtering criteria resulted a total of 98 heterozygous rare
sequence variants in 12 sporadic cases, with an average of eight rare sequence variants per spo-
radic case (S2 Table; S3–S14 Tables). A total of nine heterozygous overlapping variants were
detected in four families, with an average of two variants in each family. In two families, no
overlapping rare variants were identified (S2 Table).
Rare variants in sporadic CD cases. We first examined genes that have previously been
described to carry rare variants in macular degeneration, for rare sequence variants in 12 spo-
radic CD cases. In eight sporadic cases, we detected eight heterozygous rare sequence variants
in six macular degeneration genes (CFH; FBLN1, OMIM 135820; FBLN3/EFEMP1, OMIM
601548; FBLN5, OMIM 604580;HMCN1, OMIM 608548; FBN2, OMIM 612570) (Table 1).
All rare sequence variants in the CFH (p.Ala173Gly; p.Gln950His/rs149474608), FBLN1 (p.
His695Arg/rs13268), EFEMP1 (p.Asp49Ala/rs55849640), FBLN5 (p.Val126Met/rs61734479),
HMCN1 (p.Lys2559Asn/rs139899015), and FBN2 (p.Pro326Ser/rs28763954; p.His1381Asn/
rs78727187) genes were confirmed by Sanger sequencing. Five of these variants (p.Gln950His
(CFH), p.His695Arg (FBLN1), p.Val126Met (FBLN5), p.Lys2559Asn (HMCN1), and p.
His1381Asn (FBN2)) are predicted to be damaging by prediction tools SIFT and PolyPhen2.
However, three variants (p.Ala173Gly (CFH), p.Asp49Ala (EFEMP1), and p.Pro326Ser
(FBN2)) are predicted to be damaging by one of these prediction tools. Evolutionary conserva-
tion of altered bases were predicted using the Phylop program. The variants in the FBLN1,
EFEMP1, FBLN5,HMCN1, and FBN2 genes are conserved, whereas the c.518C>G (p.
Ala173Gly) and c.2850G>T (p.Gln950His) variants in the CFH gene are less conserved
(Table 1).
We next sought for genes that were burdened recurrently with rare sequence variants in at
least three sporadic cases. We detected two recurrent candidate genes (FGL1, OMIM 605776;
COL15A1, OMIM 120325) that harbored rare sequence variants in a total of six sporadic cases
Table 1. Rare missense variants identified in knownmacular degeneration genes in 12 sporadic CD subtype of AMD cases byWES.
Gene Change in dbSNP Prediction algorithms Conservation # Cases (Fig 2)
Nucleotide Protein ID MAF (%) SIFT PolyPhen2 Phylop (Base level)
CFH c.518C>G p.Ala173Gly NA 0 Deleterious Benign 0.3 1 (3AB)
CFH c.2850G>T p.Gln950His rs149474608 0.002 Deleterious Damaging -0.7 1 (9AB)
FBLN1 c.2084A>G p.His695Arg rs13268 0.007 Deleterious Damaging 4.2 1 (2AB)
FBLN3/EFEMP1 c.146T>G p.Asp49Ala rs55849640 0.0004 Deleterious Benign 2.3 1 (12AB)
FBLN5 c.376C>T p.Val126Met rs61734479 0.0008 Deleterious Damaging 4.0 1 (10AB)
FBLN6/HMCN1 c.7677G>C p.Lys2559Asn rs139899015 0 Deleterious Damaging 1.2 1 (8AB)
FBN2 c.976G>A p.Pro326Ser rs28763954 0.003 Deleterious Benign 2.7 1 (9AB)
FBN2 c.4141G>T p.His1381Asn rs78727187 0 Deleterious Damaging 5.9 1 (7AB)
CD, cuticular drusen; AMD, age-related macular degeneration; WES, whole exome sequencing; MAF, minor allele frequency; SIFT, sorting intolerant from
tolerant; PolyPhen2, polymorphism phenotyping; Phylop score (< 0, less conserved; 0, neutral; > 0 conserved; a large score indicates high conservation);
NA, not applicable
doi:10.1371/journal.pone.0152047.t001
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(Table 2). Sanger sequencing confirmed variants in the FGL1 (p.Tyr140Phe/rs35431851; p.
Trp256Leu/rs2653414), and COL15A1 (p.Phe851Leu/rs35901514) genes, while a variant in the
COL15A1 (p.Lys1365Ile) gene was not confirmed by Sanger sequencing (S15 Table). Of the
confirmed variants, a rare variant (FGL1, p.Trp256Leu/rs2653414) is detected recurrently in
two sporadic cases. Two variants in FGL1 (p.Tyr140Phe; p.Trp256Leu) gene are predicted to
be damaging by both SIFT and PolyPhen2. The variant in the COL15A1 gene (p.Phe851Leu) is
predicted to be damaging by one of two algorithms. The Phylop program predicted that all
three variants in the FGL1 and COL15A1 genes are evolutionarily conserved (Table 2).
Rare variants in CD families. We detected four heterozygous overlapping rare sequence
variants in four candidate genes (TFPI, OMIM 152310; TLR1, OMIM, 601194; COL15A1;
C1QBP, OMIM 601269) in affected members of family 1 (Table 3). Family 3 harbored three
heterozygous overlapping rare sequence variants in three candidate genes (DDR1, OMIM
600408; VWF, OMIM 613160; SLC12A3, OMIM 600968) (Table 3). Families 2 and 6 harbored
one heterozygous overlapping rare variant in one candidate gene each (Family 2: ADAMTS20,
OMIM 611681; Family 6: ITGA1, OMIM 192968), but both variants were not confirmed by
Sanger sequencing (S15 Table). No overlapping rare sequence variants were detected in candi-
date genes in affected members of families 4 and 5 (S2 Table).
In family 1, all overlapping rare sequence variants (p.Val292Met/rs5940, TFPI; p.Gln380,
TLR1; p.Pro705Leu/rs41308900, COL15A1; p.Thr130Met/rs56014026, C1QBP) in candidate
genes were confirmed by Sanger sequencing (Table 3). Two variants, p.Val292Met (TFPI) and
p.Pro705Leu (COL15A1), are predicted to be damaging by both SIFT and PolyPhen2, while a
variant p.Thr130Met (C1QBP) is predicted to be damaging by one of two algorithms.
Table 2. Recurrent missense variants identified in two of 289 candidate genes in 12 sporadic CD subtype of AMD cases byWES.
Gene Change in dbSNP Prediction algorithms Conservation # Cases (Fig 2)
Nucleotide Protein ID MAF (%) SIFT PolyPhen2 Phylop (Base level)
FGL1 c.419T>A p.Tyr140Phe rs35431851 0.007 Deleterious Damaging 4.6 1 (11AB)
FGL1 c.767C>A p.Trp256Leu rs2653414 0.009 Deleterious Damaging 5.1 2 (4AB; 6AB)
COL15A1 c.2551T>C p.Phe851Leu rs35901514 0.003 Tolerated Damaging 2.8 1 (2AB)
CD, cuticular drusen; AMD, age-related macular degeneration; WES, whole exome sequencing; MAF, minor allele frequency; SIFT, sorting intolerant from
tolerant; PolyPhen2, polymorphism phenotyping; Phylop score (< 0, less conserved; 0, neutral; > 0 conserved; a large score indicates high conservation)
doi:10.1371/journal.pone.0152047.t002
Table 3. Overlapping rare sequence variants identified in seven of 289 candidate genes in affected members of CD families byWES.
Gene Change in dbSNP Prediction algorithms Conservation Family number
Nucleotide Protein ID MAF (%) SIFT PolyPhen2 Phylop (Base level)
TFPI c.874G>A p.Val292Met rs5940 0.008 Deleterious Damaging 0.5 1
TLR1 c.1138C>T p.Gln380* NA 0 NA NA 1.3 1
COL15A1 c.2114C>T p.Pro705Leu rs41308900 0.007 Deleterious Damaging 1.9 1
C1QBP c.389C>T p.Thr130Met rs56014026 0.007 Tolerated Damaging 3.4 1
DDR1 c.1093A>T p.Ile365Phe rs143367160 0.003 Deleterious Benign 1.6 3
VWF c.2771C>T p.Arg924Gln rs33978901 0.007 Tolerated Benign 1.4 3
SLC12A3 c.2883+1 G>T Splice-donor rs199974259 0 NA NA 5.2 3
CD, cuticular drusen; WES, whole exome sequencing; MAF, minor allele frequency; SIFT, sorting intolerant from tolerant; PolyPhen2, polymorphism
phenotyping; Phylop score (< 0, less conserved; 0, neutral; > 0 conserved; a large score indicates high conservation); NA, not applicable
doi:10.1371/journal.pone.0152047.t003
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Evolutionary conservation suggested that variants in the TFPI, TLR1, COL15A1, and C1QBP
genes are conserved. We next checked for segregation of all confirmed variants with CD in the
additional members of family 1 by Sanger sequencing. Variant p.Pro705Leu in the COL15A1
gene segregated heterozygously with CD in this family, although unaffected family members
above age 60 were not available in this family. All other variants were not present in one or two
affected members of a family, and thus did not segregate with CD in family 1 (Fig 3).
Family 3 harbored three overlapping rare sequence variants (p.Ile365Phe/rs143367160,
DDR1; p.Arg924Gln/rs33978901, VWF; c.2883+1G>T/rs199974259, SLC12A3), which were
all confirmed by Sanger sequencing. Variant p.Ile365Phe in the DDR1 gene is predicted to be
damaging by one of two prediction algorithms, while the p.Arg924Gln variant in the VWF
gene is predicted not to be damaging by both SIFT and PolyPhen2 prediction algorithms. All
three variants are evolutionarily conserved. These variants subsequently were analyzed for seg-
regation with CD in two additional family members of family 3. Variant p.Ile365Phe in the
DDR1 gene did not show segregation, as it was not present in an affected member of the family.
The splice donor variant, c.2883+1G>T, in the SLC12A3 gene also did not segregate, as it was
found to be present in an unaffected member and was not present in an affected member of the
family. The missense variant p.Arg924Gln in the VWF gene is present in three affected mem-
bers and one unaffected member of the family (Fig 3).
The exomes of the six families were also analyzed for variants in all genes of the exome that
were shared among all affected individuals of all six families. We filtered the exome data for
rare non-synonymous, coding indels, and splice acceptor and donor site variants with a MAF
Fig 3. Segregation analysis of rare sequence variants identified in candidate genes in cuticular drusen (CD) families by whole exome sequencing
(WES).Circles, females; squares, males; empty symbols, unaffected; black symbols, affected; asterisks, exome sequenced individuals; ‘+’ symbol, wild type
allele; ‘m’ symbol, mutant type allele. The age at participation is specified below the symbols.
doi:10.1371/journal.pone.0152047.g003
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1% in dbSNP and in our in-house exome database. These filtering criteria did not identify
any rare sequence variants in a single gene that segregate with CD in the six families.
Discussion
In the present study, we found rare sequence variants in two genes which previously were
shown to harbor rare variants in CD (CFH and FBLN5) [5,11]. In addition, we found heterozy-
gous rare sequence variants (MAF0.01) in several extracellular matrix (ECM) genes, which
include FBLN1, FBLN3/EFEMP1, FBLN5, FBLN6/HMCN1, FBN2, and COL15A1, in sporadic
cases and families with the CD subtype of AMD byWES (Tables 1 and 2). Two rare pathogenic
variants were identified in the COL15A1 gene: one in a sporadic case and another was found to
segregate in a family with six affected individuals with CD. In addition, two rare pathogenic
variants were identified in the FGL1 gene in three unrelated CD cases.
Variants in the CFH gene are major risk factors for both AMD and CD [10,11,19]. In this
study, we identified two missense variants (p.Ala173Gly and p.Gln950His) that were previously
identified by Sanger sequencing of the CFH gene in the same patients of the CD subtype of
AMD phenotype [12].
The fibulins are ECM proteins that are characterized by tandem arrays of epidermal growth
factor (EGF)—like domains, and are widely expressed in basement membranes. A previous
study suggests that a single mutation (p.Arg345Trp) in the last EGF domain of FBLN3/
EFEMP1 gene causes Doyne honeycomb retinal dystrophy (DHRD; OMIM 126600) [21]. We
identified an evolutionarily conserved rare sequence variant (p.Asp49Ala) in the first EGF
domain of FBLN3/EFEMP1 gene in a sporadic CD patient. This suggests that variants in the
FBLN3/EFEMP1 gene may represent risk factors for the CD phenotype. We also identified a
missense variant (p.Val126Met) in the FBLN5 gene, which was previously reported in the
Dutch population (AMD cases 1/291; controls 5/91), suggesting that this variant is not rare in
the Dutch population [22]. Therefore, the p.Val126Met variant in the FBLN5 gene may not be
a causal variant for CD. However, missense variants in the FBLN5 gene have previously been
associated with AMD (P< 0.01) and the retinal images of patients showed a peculiar CD phe-
notype, which suggests that other variants in the FBLN5 gene are a risk factor for both the
AMD and CD phenotypes [5,22].
The ECM is an acellular component that provides physical and biochemical support for sur-
rounding cells in all tissues and organs, and constantly undergoes remodeling processes which
are indispensible for tissue architecture [23]. A pathological symptom of AMD phenotypes is
the formation of drusen between the retinal pigment epithelium (RPE) and Bruch’s membrane
(BrM), which is a multilayered ECM structure. The BrM is composed of central elastin fibers
sandwiched between layers of collagen [24,25]. The BrM acts as a blood-retinal barrier that reg-
ulates the diffusion of nutrients and oxygen from the choroid through the BrM to the RPE,
while the metabolic waste diffuses in an opposite direction to the choroid [26]. Several lines of
evidence suggest that ageing processes (thickening, calcification, degeneration of collagens and
elastic fibers) and alterations in the structural components in the BrM result in loss of normal
function of the BrM [27], which may result in accumulation of drusen deposits in AMD
patients. Emerging evidence suggests that alterations in specific genes encoding ECM proteins
(TIMP3, CTRP5, FBN2, and FBLN 1–6) are implicated in macular degeneration [5,21,28–30].
Recent genome-wide association studies have also identified risk variants in several ECM genes
(COL8A1, COL10A1, ADAMTS9, DDR1, TGFBR1, HTRA1, and TIMP3) [20].
The present study identified two evolutionarily conserved rare sequence variants (p.Pro705-
Leu and p.Phe851Leu) in COL15A1 in 6 affected members of a family and in a sporadic CD
patient, respectively. The p.Pro705Leu variant is predicted to be deleterious by both prediction
Whole Exome Sequencing in Age-Related Macular Degeneration
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algorithms, while the p.Phe851Leu variant is predicted to be deleterious by one of two predic-
tion algorithms. These prediction algorithms provide a quick functional annotation of variants,
but experimental validation is required to properly access the functional consequences of these
variants. The COL15A1 gene encodes collagen, type XV, alpha 1, which is widely expressed in
basement membranes [31], and in choroidal endothelial cells [32]. Since the choroid plays a
vital role in maintenance of BrM, variants in the COL15A1 gene might lead to altered proper-
ties of the choroid and/or of BrM, resulting in the formation of drusen in patients with CD.
In this study we also identified two highly conserved rare sequence variants in the FGL1
gene in three of 12 sporadic CD cases (Table 2). Both variants are predicted to be deleterious to
the normal function of the protein by prediction algorithms. Fibrinogen and fibrinogen-like
protein 1 (FGL1) belong to the fibrinogen superfamily. Fibrinogen is a precursor of fibrin clot
formation of the coagulation cascade [33,34]. A proteomic study demonstrated that FGL1 is
bound to the fibrin matrix during clot formation, suggesting that FGL1 is involved in the coag-
ulation cascade [35,36]. Interestingly, the molecular composition of drusen consist of fibrino-
gen as one of several constituents [37]. This suggests that FGL1 variants may be causative in
CD, although it is unclear on how the coagulation cascade and variants in FGL1 gene may be
implicated in AMD phenotypes.
We found no segregating rare variants among affected members of four of the six CD fami-
lies in the 289 candidate genes. In all protein-coding regions of the genome, we also found no
evidence of rare sequence variants in a single gene that segregate with CD in all families, pro-
viding evidence for genetic heterogeneity in the pathogenesis of CD. Alternatively, the disease
risk in some individuals of these families may be attributable to a combination of common
genetic and environmental factors, and as a consequence rare variants may not completely seg-
regate in these families. In a recent study we identified a clustering of known risk factors in
affected members of families with AMD, suggesting that such families may not be explained by
rare genetic variants. However, some families cannot be explained by known risk factors, and
are more likely to carry rare, highly penetrant variants [38]. Some affected family members in
the CD families examined in this study might thus have CD due to the presence of known risk
factors, and not merely by rare sequence variants. Therefore, WES based segregation analyses
may not always be the best strategy to solve AMD or CD families. However, other studies have
successfully identified rare sequence variants in AMD families by WES, e.g. in the CFH and
FBN2 genes [28,39].
In summary, WES in sporadic cases and families with the CD subtype of AMD identified
rare variants in known CD genes and several genes encoding ECM components. Rare patho-
genic variants were recurrently identified in the COL15A1 and FGL1 genes. These findings sug-
gest that alterations in the ECM and in the coagulation pathway may play a role in the
pathogenesis of CD. These candidate genes require further analyses in larger cohorts to con-
firm their involvement in the CD subtype of AMD. No evidence was found of rare sequence
variants in a single gene that segregate with CD in the six families, suggesting that the disease is
genetically heterogeneous.
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